Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015
As the death toll in the country from coronavirus jumped by a record 445 to 13,699, the Centre maintained that the number of infections per lakh population was among the lowest in the world. The new cases surged by over 10,000 for the 11th day in a row and rose by 14,821 to take the total to 4,25,282, according to health ministry data.
The FMCG index gained more than 1% on the back of stellar gains in ITC.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Revival in domestic business should also help overall revenue growth.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The BSE Mid-Cap index was currently up 0.81%.
Russia's central bank early on Tuesday raised interest rates to 17 per cent to counter the 50 per cent rouble fall in six months.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries
Ajit Mishra, vice president, Research, Religare Broking, answers your queries:
Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.
Sensex, Nifty end the day in red on unfavourable cues from global markets.
Top 5 losers include Lupin, Cipla, Sun Pharma, Dr Reddy's Lab and GAIL down 1.6%-11%.
Sun Pharma was by far the biggest gainer in the Sensex pack, surging 8.13 per cent, followed by Dr Reddy's at 4.92 per cent.
In the broader market, the S&P BSE Midcap added over 1% to finish at record closing high
The Nifty had hit its third successive record high of 7,922.70 today.
Low growth visibility and trouble with regulators have resulted in lack of interest from investors
The private companies announced projects worth Rs 11.33 lakh crore (Rs 11.33 trillion) during 2014-16.
Indian pharma firms under European drug regulator's scanner.
Experts say the stock market correction in recent times increases the risk-reward in favour of large-cap stocks.
Fixed-dose combinations are medicines that come mixed in a certain proportion.
Sun Pharmaceutical, which is growing its dermatology and ophthalmic specialty business in the US will spend $460 million on R&D.
Bharti Airtel , RCom and Tata Communications ended down between 0.1-1%.
6 locations in New Delhi and 2 in Mumbai were raided.
Rise in crude oil price and rally in global equities aided the sentiment
Rate sensitive sectors were among the top gainers with Tata Motors and ICICI Bank leading the gains on the Sensex.
FIIs are looking at the long-term story and initiatives of Indian pharma companies to transform themselves into global entities.
Ajit Mishra, vice president, Research, Religare Broking, answers readers' queries on stocks they own or want to buy.
.jpg)
In a letter to health minister Harsh Vardhan, the Indian Pharmaceutical Alliance, an industry body representing leading pharma companies, including Sun Pharma, Lupin, Dr Reddy's Labs, Cadila Health and Glenmark, stressed the need for an out-of-court settlement with health activists fighting for the rights of clinical trial participants.
Markets finished lower for the sixth consecutive day as hopes of the Goods and Services tax (GST) bill being passed in the current session of the Parliament faded considerably.
Better-than-expected financial results in Q3 due to higher revenue growth and margins in key markets fuel the rally
All the sectoral indices, led by realty, metal, consumer durables and power were trading in the negative zone on Thursday.
The broader markets were also in top gear, with the BSE midcap index surging by 2.1% at 11,431 and the smallcap index gaining 1.4% at 11,735.
Sensex, Nifty slightly upbeat, midcaps to rule markets this week.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' queries on stocks they own or want to buy.
Geopolitical concerns, earnings sees investors rush to safe haven plays post the Union Budget presentation in July.
The S&P BSE Sensex ended 190 points up at 23,382.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances